Walleye Trading’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,256
Closed -$69.3K 4266
2025
Q3
$64.9K Sell
7,256
-32,956
-82% -$305K ﹤0.01% 3879
2025
Q2
$379K Sell
40,212
-29,354
-42% -$259K ﹤0.01% 2837
2025
Q1
$754K Buy
+69,566
New +$700K ﹤0.01% 2246
2023
Q4
Sell
-13,021
Closed -$118K 5033
2023
Q3
$118K Buy
+13,021
New +$156K ﹤0.01% 3890
2019
Q3
Sell
-107,438
Closed -$1.09M 3964
2019
Q2
$1.09M Sell
107,438
-1,749
-2% -$17.6K 0.01% 1523
2019
Q1
$1.09M Sell
109,187
-3,799
-3% -$37.7K 0.01% 1574
2018
Q4
$1.11M Buy
112,986
+12,986
+13% +$127K 0.01% 1605
2018
Q3
$972K Buy
+100,000
New +$970K 0.01% 2099

Other funds holding AHCO

Walleye Trading's AHCO Position: Q4 2025 in Review

Walleye Trading sold out of AdaptHealth (AHCO) in Q4 2025, closing a stake of 7,256 shares — an estimated $69.3K sold.

Walleye Trading first reported a position in AHCO in Q3 2018 and held it in 8 quarters. The position peaked at $1.11M in Q4 2018. 231 funds tracked by Wall St. Rank hold AHCO as of Q4 2025.

  • Walleye Trading reported no remaining AdaptHealth position as of Q4 2025 after selling out during the quarter.
  • Walleye Trading sold 7,256 AdaptHealth shares in Q4 2025, an estimated $69.3K.
  • Walleye Trading first reported a position in AdaptHealth in Q3 2018 and held it in 8 quarters.
  • Walleye Trading's AdaptHealth position peaked at $1.11M in Q4 2018.
  • 231 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2025.

Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.